Medicines Act Notices




27 SEPTEMBER

NEW ZEALAND GAZETTE

3383

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Apo-Cimetidine

Active Ingredient(s):
Cimetidine 200mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer(s):
Apotex Inc, Weston, Ontario, Canada

Product:
Apo-Cimetidine

Active Ingredient(s):
Cimetidine 400mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer(s):
Apotex Inc, Weston, Ontario, Canada

Product:
Apo-Cimetidine

Active Ingredient(s):
Cimetidine 800mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer(s):
Apotex Inc, Weston, Ontario, Canada

Product:
Apo-Gliclazide

Active Ingredient(s):
Gliclazide 80mg

Dosage Form:
Tablet

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer(s):
Apotex Inc, Weston, Ontario, Canada

Product:
Probitor

Active Ingredient(s):
Omeprazole 20mg

Dosage Form:
Modified release capsule

New Zealand Sponsor:
Novartis New Zealand Limited

Manufacturer(s):
Liconsa SA, Azuqueca de Henares, Guadalajara, Spain

Dated this 18th day of September 2001.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go6684

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Ilomedin

Active Ingredient(s):
Iloprost trometamol 134µg/mL equivalent to 100µg Iloprost/mL

Dosage Form:
Solution for infusion

New Zealand Sponsor:
Schering (NZ) Limited

Manufacturer(s):
Schering AG, Wedding Plant, Berlin, Germany

Product:
WinRho SDF

Active Ingredient(s):
Anti-D (Rho) immunoglobulin 600IU equivalent to 120µg

Dosage Form:
Powder for injection

New Zealand Sponsor:
CSL (New Zealand) Limited

Manufacturer(s):
Cangene Corporation, Winnipeg, Manitoba, Canada

Dated this 18th day of September 2001.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go6685



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2001, No 132


Gazette.govt.nz PDF NZ Gazette 2001, No 132





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
18 September 2001
Medicines Act 1981, New Medicines, Distribution Consent, Cimetidine, Gliclazide, Omeprazole
  • G. R. Boyd, Chief Advisor, Safety and Regulation

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
18 September 2001
Medicines Act 1981, Changed Medicines, Distribution Consent, Iloprost, Anti-D Immunoglobulin
  • G. R. Boyd, Chief Advisor, Safety and Regulation